Reduction of Central Line–Associated Bloodstream Infections in a Pediatric Hematology/Oncology Population

Matthew Z. Wilson, Deana Deeter, Colleen Rafferty, Melanie M. Comito, Christopher S. Hollenbeak

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

This study reports the results of an initiative to reduce central line–associated bloodstream infections (CLABSIs) among pediatric hematology/oncology patients, a population at increased risk for CLABSI. The study design was a pre–post comparison of a series of specific interventions over 40 months. Logistic regression was used to determine if the risk of developing CLABSI decreased in the postintervention period, after controlling for covariates. The overall CLABSI rate fell from 9 infections per 1000 line days at the beginning of the study to zero in a cohort of 291 patients encompassing 2107 admissions. Admissions during the intervention period had an 86% reduction in odds of developing a CLABSI, controlling for other factors. At the study team’s institution, an initiative that standardized blood culturing techniques, lab draw times, line care techniques, and provided physician and nurse education was able to eliminate CLABSI among pediatric hematology/oncology patients.

Original languageEnglish (US)
Pages (from-to)484-490
Number of pages7
JournalAmerican Journal of Medical Quality
Volume29
Issue number6
DOIs
StatePublished - Nov 8 2014

Fingerprint

Hematology
Pediatrics
Infection
Population
Logistic Models
Nurses
Physicians
Education

All Science Journal Classification (ASJC) codes

  • Health Policy

Cite this

@article{5d811ce58e6f4f3bb6e912f907620124,
title = "Reduction of Central Line–Associated Bloodstream Infections in a Pediatric Hematology/Oncology Population",
abstract = "This study reports the results of an initiative to reduce central line–associated bloodstream infections (CLABSIs) among pediatric hematology/oncology patients, a population at increased risk for CLABSI. The study design was a pre–post comparison of a series of specific interventions over 40 months. Logistic regression was used to determine if the risk of developing CLABSI decreased in the postintervention period, after controlling for covariates. The overall CLABSI rate fell from 9 infections per 1000 line days at the beginning of the study to zero in a cohort of 291 patients encompassing 2107 admissions. Admissions during the intervention period had an 86{\%} reduction in odds of developing a CLABSI, controlling for other factors. At the study team’s institution, an initiative that standardized blood culturing techniques, lab draw times, line care techniques, and provided physician and nurse education was able to eliminate CLABSI among pediatric hematology/oncology patients.",
author = "Wilson, {Matthew Z.} and Deana Deeter and Colleen Rafferty and Comito, {Melanie M.} and Hollenbeak, {Christopher S.}",
year = "2014",
month = "11",
day = "8",
doi = "10.1177/1062860613509401",
language = "English (US)",
volume = "29",
pages = "484--490",
journal = "American Journal of Medical Quality",
issn = "1062-8606",
publisher = "SAGE Publications Inc.",
number = "6",

}

Reduction of Central Line–Associated Bloodstream Infections in a Pediatric Hematology/Oncology Population. / Wilson, Matthew Z.; Deeter, Deana; Rafferty, Colleen; Comito, Melanie M.; Hollenbeak, Christopher S.

In: American Journal of Medical Quality, Vol. 29, No. 6, 08.11.2014, p. 484-490.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Reduction of Central Line–Associated Bloodstream Infections in a Pediatric Hematology/Oncology Population

AU - Wilson, Matthew Z.

AU - Deeter, Deana

AU - Rafferty, Colleen

AU - Comito, Melanie M.

AU - Hollenbeak, Christopher S.

PY - 2014/11/8

Y1 - 2014/11/8

N2 - This study reports the results of an initiative to reduce central line–associated bloodstream infections (CLABSIs) among pediatric hematology/oncology patients, a population at increased risk for CLABSI. The study design was a pre–post comparison of a series of specific interventions over 40 months. Logistic regression was used to determine if the risk of developing CLABSI decreased in the postintervention period, after controlling for covariates. The overall CLABSI rate fell from 9 infections per 1000 line days at the beginning of the study to zero in a cohort of 291 patients encompassing 2107 admissions. Admissions during the intervention period had an 86% reduction in odds of developing a CLABSI, controlling for other factors. At the study team’s institution, an initiative that standardized blood culturing techniques, lab draw times, line care techniques, and provided physician and nurse education was able to eliminate CLABSI among pediatric hematology/oncology patients.

AB - This study reports the results of an initiative to reduce central line–associated bloodstream infections (CLABSIs) among pediatric hematology/oncology patients, a population at increased risk for CLABSI. The study design was a pre–post comparison of a series of specific interventions over 40 months. Logistic regression was used to determine if the risk of developing CLABSI decreased in the postintervention period, after controlling for covariates. The overall CLABSI rate fell from 9 infections per 1000 line days at the beginning of the study to zero in a cohort of 291 patients encompassing 2107 admissions. Admissions during the intervention period had an 86% reduction in odds of developing a CLABSI, controlling for other factors. At the study team’s institution, an initiative that standardized blood culturing techniques, lab draw times, line care techniques, and provided physician and nurse education was able to eliminate CLABSI among pediatric hematology/oncology patients.

UR - http://www.scopus.com/inward/record.url?scp=84908511807&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908511807&partnerID=8YFLogxK

U2 - 10.1177/1062860613509401

DO - 10.1177/1062860613509401

M3 - Article

C2 - 24226650

AN - SCOPUS:84908511807

VL - 29

SP - 484

EP - 490

JO - American Journal of Medical Quality

JF - American Journal of Medical Quality

SN - 1062-8606

IS - 6

ER -